PTCT - Financial Reports List - PTC Therapeutics, Inc. - IntrinsicAlpha

PTC Therapeutics, Inc. PTCT

Healthcare - Biotechnology - NASDAQ - US

$ 42.915

-7.47 %

$ 3.38 B

Market Cap

-9.14

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-30.58%	57.71%	-5204.78%
Annual Report	FY	10-K	2024-12-31	-13.97%	42.02%	13.40%
Quarterly Report	Q3	8-K	2024-09-30	0.11%	19.79%	53.87%
Quarterly Report	Q2	8-K	2024-06-30	-12.68%	50.13%	84.08%
Quarterly Report	Q1	8-K	2024-03-31	-4.66%	34.10%	60.46%
Quarterly Report	Q4	8-K	2023-12-31	83.41%	8.83%	101.56%
Annual Report	FY	10-K	2023-12-31	34.20%	-12.09%	20.58%
Quarterly Report	Q3	8-K	2023-09-30	-9.46%	-21.64%	-60.80%
Quarterly Report	Q2	8-K	2023-06-30	29.17%	-30.77%	-94.81%
Quarterly Report	Q1	8-K	2023-03-31	48.17%	-9.65%	-33.16%

1